NCT02224430View on ClinicalTrials.gov

Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DEVICE

schizophrenia/schizoaffective disorder.

Participants with schizophrenia/schizoaffective disorder will be observed remotely and at weekly/biweekly laboratory visits over a period of 16 weeks or until relapse occurs.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT02224430 - Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors | Biotech Hunter | Biotech Hunter